Optimal management of night eating syndrome: challenges and solutions.

Abstract:

:Night Eating Syndrome (NES) is a unique disorder characterized by a delayed pattern of food intake in which recurrent episodes of nocturnal eating and/or excessive food consumption occur after the evening meal. NES is a clinically important disorder due to its relationship to obesity, its association with other psychiatric disorders, and problems concerning sleep. However, NES often goes unrecognized by both health professionals and patients. The lack of knowledge regarding NES in clinical settings may lead to inadequate diagnoses and inappropriate treatment approaches. Therefore, the proper diagnosis of NES is the most important issue when identifying NES and providing treatment for this disorder. Clinical assessment tools such as the Night Eating Questionnaire may help health professionals working with populations vulnerable to NES. Although NES treatment studies are still in their infancy, antidepressant treatments and psychological therapies can be used for optimal management of patients with NES. Other treatment options such as melatonergic medications, light therapy, and the anticonvulsant topiramate also hold promise as future treatment options. The purpose of this review is to provide a summary of NES, including its diagnosis, comorbidities, and treatment approaches. Possible challenges addressing patients with NES and management options are also discussed.

authors

Kucukgoncu S,Midura M,Tek C

doi

10.2147/NDT.S70312

subject

Has Abstract

pub_date

2015-03-19 00:00:00

pages

751-60

eissn

1176-6328

issn

1178-2021

pii

ndt-11-751

journal_volume

11

pub_type

杂志文章,评审
  • The abnormal activation of D1R/Shp-2 complex involved in levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson's rats.

    abstract:Background:Levodopa-induced dyskinesia (LID) is a troublesome problem in the treatment of Parkinson's disease (PD). The mechanisms of LID are still mysterious. Recently, the interaction between Shp-2 and D1 dopamine receptor (D1R) has been identified to be indispensable in the D1R-mediated extracellular signal-regulate...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S162562

    authors: Wu N,Wan Y,Song L,Qi C,Liu Z,Gan J

    更新日期:2018-07-05 00:00:00

  • Efficacy of ginkgo biloba extract as augmentation of venlafaxine in treating post-stroke depression.

    abstract:Background:Post-stroke depression (PSD) is one of the most common psychiatric diseases afflicting stroke survivors. This study was conducted to assess the efficacy of ginkgo biloba extract as augmentation of venlafaxine in treating PSD. Methods:The included PSD patients were randomly assigned into the experiment group...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S215191

    authors: Liang ZH,Jia YB,Wang ML,Li ZR,Li M,Yun YL,Zhu RX

    更新日期:2019-09-03 00:00:00

  • Impulsivity, Unplanned Pregnancies, and Contraception Among Women with Bipolar Disorder.

    abstract:Background:Impulsivity is one of the principal symptoms of bipolar and related disorders (BD). Unsafe sex and unplanned pregnancies are serious problems in clinical practice. The aim of this study was to investigate impulsivity levels, contraception methods, and levels of planned pregnancies among women with bipolar an...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S238887

    authors: Zengin Eroglu M,Lus MG

    更新日期:2020-02-07 00:00:00

  • Thyroid functions in patients with bipolar disorder and the impact of quetiapine monotherapy: a retrospective, naturalistic study.

    abstract:Objective:Previous studies have demonstrated a potentially close relationship between mood disorders and thyroid abnormalities. The aims of this study are to investigate: 1) whether significant differences of thyroid profiles exist between manic and depressive episodes in patients with bipolar disorder (BD); 2) the imp...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S196661

    authors: Li C,Lai J,Huang T,Han Y,Du Y,Xu Y,Hu S

    更新日期:2019-08-09 00:00:00

  • Disrupted Brain Entropy And Functional Connectivity Patterns Of Thalamic Subregions In Major Depressive Disorder.

    abstract:Purpose:Entropy analysis of resting-state functional magnetic resonance imaging (R-fMRI) has recently been adopted to characterize brain temporal dynamics in some neuropsychological or psychiatric diseases. Thalamus-related dysfunction might be a potential trait marker of major depressive disorder (MDD), but the abnorm...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S220743

    authors: Xue SW,Wang D,Tan Z,Wang Y,Lian Z,Sun Y,Hu X,Wang X,Zhou X

    更新日期:2019-09-11 00:00:00

  • Orthostatic hypotension and dementia incidence: links and implications.

    abstract::Orthostatic hypotension (OH) is a common condition, particularly in patients with α-synucleinopathies such as Parkinson's disease, and has a significant impact on activities of daily living and quality of life. Recent data suggest an association with cognitive impairment. Herein, we review the evidence that OH increas...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S182123

    authors: Robertson AD,Udow SJ,Espay AJ,Merola A,Camicioli R,Lang AE,Masellis M

    更新日期:2019-08-02 00:00:00

  • The use of natalizumab for multiple sclerosis.

    abstract::Natalizumab is a monoclonal antibody that acts as an α4 integrin antagonist to prevent leukocyte trafficking into the central nervous system. It is US Food and Drug Administration (FDA) approved for the treatment of relapsing-remitting multiple sclerosis (RRMS). Natalizumab demonstrated high efficacy in Phase III tria...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S114636

    authors: Brandstadter R,Katz Sand I

    更新日期:2017-06-28 00:00:00

  • Reliability and validity of the Depression and Somatic Symptoms Scale among patients with chronic low back pain.

    abstract:Background:The Depression and Somatic Symptoms Scale (DSSS), which is a free scale that includes a depression subscale (DS) and a somatic subscale (SS), was developed to evaluate depression and somatic symptoms simultaneously. This study aimed to examine the reliability and validity of the DSSS among patients with chro...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S188277

    authors: Liu CH,Fu TS,Lee CP,Hung CI

    更新日期:2019-01-14 00:00:00

  • Elevated factor VIII level and stroke in patients without traditional risk factors associated with cardiovascular diseases.

    abstract:INTRODUCTION:Hemostasis is affected by interactions between physiological processes, including those connected with the coagulation system, whose essence is converting fibrinogen into fibrin. The role of factor VIII (FVIII) consists in activating factor X, which directly participates in the generation of thrombin, whic...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S43461

    authors: Lasek-Bal A,Puz P,Kazibutowska Z

    更新日期:2013-01-01 00:00:00

  • Towards Horizon 2020: challenges and advances for clinical mental health research - outcome of an expert survey.

    abstract:BACKGROUND:The size and increasing burden of disease due to mental disorders in Europe poses substantial challenges to its population and to the health policy of the European Union. This warrants a specific research agenda concerning clinical mental health research as one of the cornerstones of sustainable mental healt...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S59958

    authors: van der Feltz-Cornelis CM,van Os J,Knappe S,Schumann G,Vieta E,Wittchen HU,Lewis SW,Elfeddali I,Wahlbeck K,Linszen D,Obradors-Tarragó C,Haro JM

    更新日期:2014-06-27 00:00:00

  • Assessing public speaking fear with the short form of the Personal Report of Confidence as a Speaker scale: confirmatory factor analyses among a French-speaking community sample.

    abstract:BACKGROUND:The main aim of this study was to assess the reliability and structural validity of the French version of the 12-item version of the Personal Report of Confidence as Speaker (PRCS), one of the most promising measurements of public speaking fear. METHODS:A total of 611 French-speaking volunteers were adminis...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S43097

    authors: Heeren A,Ceschi G,Valentiner DP,Dethier V,Philippot P

    更新日期:2013-01-01 00:00:00

  • Transcranial magnetic stimulation for the treatment of anxiety disorder.

    abstract::Anxiety is currently one of the main mood changes and can impair the quality of life of the individual when associated with other neurological or psychiatric disorders. Neuromodulation has been highlighted as a form of treatment of several pathologies, including those involving anxiety symptoms. Among the neuromodulat...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S201407

    authors: Rodrigues PA,Zaninotto AL,Neville IS,Hayashi CY,Brunoni AR,Teixeira MJ,Paiva WS

    更新日期:2019-09-23 00:00:00

  • Autoimmune encephalitis in psychiatric institutions: current perspectives.

    abstract::Autoimmune encephalitis is a rare and newly described group of diseases involving autoantibodies directed against synaptic and neuronal cell surface antigens. It comprises a wide range of neuropsychiatric symptoms. Sensitive and specific diagnostic tests such as cell-based assay are primordial for the detection of neu...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S82380

    authors: Bost C,Pascual O,Honnorat J

    更新日期:2016-10-27 00:00:00

  • Erratum: Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations [Corrigendum].

    abstract::[This corrects the article on p. 1535 in vol. 14, PMID: 29950838.]. ...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,已发布勘误

    doi:10.2147/NDT.S205205

    authors:

    更新日期:2019-03-05 00:00:00

  • Evaluation of BPPV with vertebral artery values.

    abstract:Objectives:The aim of this study was to investigate the association between benign paroxysmal positional vertigo (BPPV) and vertebral artery (VA) flow rates and diameters by using Doppler ultrasonography in patients with BPPV. Additionally, we aimed to investigate the abnormalities of VA values obtained by extracranial...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S169991

    authors: Yazıcı A,İnanç Y

    更新日期:2018-08-06 00:00:00

  • Bridging the Gap Between Physical Health and Autism Spectrum Disorder.

    abstract::Autism spectrum disorder (ASD) is a highly complex and heterogeneous developmental disorder that affects how individuals communicate with other people and relate to the world around them. Research and clinical focus on the behavioural and cognitive manifestations of ASD, whilst important, have obscured the recognition...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S251394

    authors: Sala R,Amet L,Blagojevic-Stokic N,Shattock P,Whiteley P

    更新日期:2020-06-30 00:00:00

  • Reversible global aphasia as a side effect of quetiapine: a case report and literature review.

    abstract::Quetiapine is an atypical antipsychotic agent which is also prescribed for delirium due to its anti-dopaminergic effects; aphasia is an unusual side effect associated with the drug. Here, we report the case of an 83-year-old woman who was prescribed quetiapine (50 mg per day) for delirium. Unexpected, global aphasia o...

    journal_title:Neuropsychiatric disease and treatment

    pub_type:

    doi:10.2147/NDT.S141273

    authors: Chien CF,Huang P,Hsieh SW

    更新日期:2017-08-28 00:00:00

  • Effectiveness of high-intensity interval training on the mental and physical health of people with chronic schizophrenia.

    abstract:BACKGROUND:Low-volume high-intensity interval training (HIIT) is emerging as a time-efficient exercise strategy for improving cardiorespiratory fitness and for controlling blood sugar levels and hypertension. In addition, patient acceptance of HIIT may improve adherence to exercise programs. This study evaluated the ef...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S81482

    authors: Wu MH,Lee CP,Hsu SC,Chang CM,Chen CY

    更新日期:2015-05-25 00:00:00

  • Psychogenic non-epileptic seizures: so-called psychiatric comorbidity and underlying defense mechanisms.

    abstract::In Diagnostic and Statistical Manual of Mental Disorders, fifth edition, psychogenic non-epileptic seizures (PNES) do not have a unique classification as they can be found within different categories: conversion, dissociative, and somatization disorders. The ICD-10, instead, considers PNES within dissociative disorder...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S82079

    authors: Beghi M,Negrini PB,Perin C,Peroni F,Magaudda A,Cerri C,Cornaggia CM

    更新日期:2015-09-30 00:00:00

  • Laser interstitial thermal therapy for the treatment of epilepsy: evidence to date.

    abstract::Medically intractable epilepsy is associated with increased morbidity and mortality. For those with focal epilepsy and correlated electrophysiological or radiographic features, open surgical resection can achieve high rates of seizure control, but can be associated with neurologic deficits and cognitive effects. Recen...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S139544

    authors: Shukla ND,Ho AL,Pendharkar AV,Sussman ES,Halpern CH

    更新日期:2017-09-26 00:00:00

  • Psychotherapy and medication management strategies for obsessive-compulsive disorder.

    abstract::Obsessive-compulsive disorder (OCD) is a chronic anxiety disorder. While medication and psychotherapy advances have been very helpful to patients, many patients do not respond adequately to initial trials of serotonergic medication or cognitive-behavioral therapy (CBT) and require multiple treatment trials or combinat...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S13205

    authors: Walsh KH,McDougle CJ

    更新日期:2011-01-01 00:00:00

  • Association of metabotropic glutamate receptor 3 gene polymorphisms with schizophrenia risk: evidence from a meta-analysis.

    abstract::To date, the role of metabotropic glutamate receptor 3 (GRM3) rs274622, rs1468412, rs917071, rs6465084, and rs2299225 polymorphisms in schizophrenia remains controversial. To provide a clearer picture for the effect of the five most studied GRM3 polymorphisms on risk of schizophrenia, this meta-analysis with eligible ...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S77966

    authors: Yang X,Wang G,Wang Y,Yue X

    更新日期:2015-03-25 00:00:00

  • Comparison of treatment outcomes in severe personality disorder patients with or without substance use disorders: a 36-month prospective pragmatic follow-up study.

    abstract:BACKGROUND:Concurrent personality disorder (PD) and substance use disorder (SUD) are common in clinical practice. However, SUD is the main criterion for study exclusion in most psychotherapeutic studies of PD. As a result, data on treatment outcomes in patients with concurrent PD/SUD are scarce. METHODS:The study samp...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S106270

    authors: Lana F,Sánchez-Gil C,Adroher ND,Pérez V,Feixas G,Martí-Bonany J,Torrens M

    更新日期:2016-06-21 00:00:00

  • Stigmasterol Exerts Neuro-Protective Effect Against Ischemic/Reperfusion Injury Through Reduction Of Oxidative Stress And Inactivation Of Autophagy.

    abstract:Purpose:Stroke remains the primary cause of pain, suffering, and death in patients. One of the major thrusts in stroke therapy is to find an effective prevention strategy. Objectives of this study are to testify the neuro-protection effect of stigmasterol in ischemic/reperfusion injury model. Methods:The dosage-depend...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S220224

    authors: Sun J,Li X,Liu J,Pan X,Zhao Q

    更新日期:2019-10-18 00:00:00

  • MiRNA-532-5p Regulates CUMS-Induced Depression-Like Behaviors and Modulates LPS-Induced Proinflammatory Cytokine Signaling by Targeting STAT3.

    abstract:Background:It is known that miR-532-5p is critical for neuronal differentiation. However, the role of miR-532-5p in depression remains unknown. This study aimed to investigate the role and mechanism of miR-532-5p in major depressive disorder (MDD). Methods:The depression mice model was established by chronic unpredict...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S251152

    authors: Yan X,Zeng D,Zhu H,Zhang Y,Shi Y,Wu Y,Tang H,Li D

    更新日期:2020-11-12 00:00:00

  • Complex obsessive compulsive and impulsive symptoms in Tourette's syndrome.

    abstract::Obsessive compulsive and impulsive symptoms are prevalent in patients with Tourette's Syndrome (TS) and well recognized as part of the TS spectrum. However, some complex obsessive compulsive and impulsive behaviors may be mistaken for other symptoms, such as complex tics or psychotic behavior. In addition, the overlap...

    journal_title:Neuropsychiatric disease and treatment

    pub_type:

    doi:

    authors: Palumbo D,Kurlan R

    更新日期:2007-01-01 00:00:00

  • Plasma complement component 4 increases in patients with major depressive disorder.

    abstract::Elevation of plasma inflammatory factors in major depressive disorder (MDD) has been repeatedly observed, but contradictory results have also been reported. Alteration of complement components in MDD may also contribute to the pathophysiology of MDD by participating in inflammation. The recent findings that complement...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S151238

    authors: Wei J,Liu Y,Zhao L,Yang X,Ni P,Wang Y,Li T,Ma X

    更新日期:2017-12-20 00:00:00

  • Profile of inhaled levodopa and its potential in the treatment of Parkinson's disease: evidence to date.

    abstract::Inhaled levodopa is a newly emerging therapeutic option in the treatment of "off " symptoms associated with Parkinson's disease (PD). Its mode of delivery offers more rapid absorption of levodopa and shorter onset of clinical benefit compared to oral formulations, and has been shown to be feasible for use in patients ...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章,评审

    doi:10.2147/NDT.S147633

    authors: Patel AB,Jimenez-Shahed J

    更新日期:2018-11-02 00:00:00

  • Ultrastructural mitochondria changes in perihematomal brain and neuroprotective effects of Huperzine A after acute intracerebral hemorrhage.

    abstract:AIM:The purpose of the study was to observe the ultrastructural changes of neuronal mitochondria in perihematomal brain tissue and assess the therapeutic potential of Huperzine A (HA, a mitochondrial protector) following intracerebral hemorrhage (ICH). METHODS:Brain hemorrhage was induced in adult Sprague Dawley rats ...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S92158

    authors: Lu H,Jiang M,Lu L,Zheng G,Dong Q

    更新日期:2015-10-13 00:00:00

  • Metabolite-related antidepressant action of diterpene ginkgolides in the prefrontal cortex.

    abstract:Purpose:Ginkgo biloba extract (GBE) contains diterpene ginkgolides (DGs), which have been shown to have neuroprotective effects by a number of previous studies. We previously demonstrated part of the action of DG. However, the impact of DG on the prefrontal cortex (PFC) remains unclear. Here, we evaluated the effects o...

    journal_title:Neuropsychiatric disease and treatment

    pub_type: 杂志文章

    doi:10.2147/NDT.S161351

    authors: Hu Q,Shen P,Bai S,Dong M,Liang Z,Chen Z,Wang W,Wang H,Gui S,Li P,Xie P

    更新日期:2018-04-13 00:00:00